GEHC GE HealthCare Technologies Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
17:56
Jul 29
Jul 29
GE HealthCare's post-earnings jump and reaffirmed guidance reflect a neutral hold rating.
GE HealthCare's post-earnings jump and reaffirmed guidance reflect a neutral hold rating from Seeking Alpha's quant system, not a directional trade call.
14:01
Jul 29
Jul 29
GE HealthCare CEO Peter Arduini reported 11% orders growth driven by broad-based execution.
GE HealthCare CEO Peter Arduini reported 11% orders growth driven by broad-based execution across imaging and procedure-based businesses with no pullback seen.
12:30
Jul 29
Jul 29
Management maintains full-year guidance and expresses confidence in medium-term targets, underpinned by robust order growth (11%) and a strong product pipeline, although a soft PCS segment remains a short-term drag.
HIGH
12:01
Jul 29
Jul 29
Premarket movers include Avantor rising 4% on earnings beat.
Premarket movers include Avantor rising 4% on earnings beat, Bloom Energy jumping 8% on strong results, Caterpillar falling 4% after Baird downgrade, and Ford rising 5% on raised profit outlook.
11:47
Jul 29
Jul 29
US pre-market movers report shows mixed earnings reactions with Meta and Microsoft slightly.
US pre-market movers report shows mixed earnings reactions with Meta and Microsoft slightly higher while NXPI, SWKS, VRT, VFC, HUM, and PG decline and STX, TER, F, BE, GEHC, GFS, JCI, and GRMN gain on their respective results and guidance.
10:29
Jul 29
Jul 29
GE Healthcare reported Q2 2026 adjusted EPS of $1.13 beating estimates and reaffirmed its.
GE Healthcare reported Q2 2026 adjusted EPS of $1.13 beating estimates and reaffirmed its full-year 2026 guidance.
10:24
Jul 29
Jul 29
GE Healthcare beats Q2 2026 earnings estimates on adjusted EPS, EBIT.
GE Healthcare beats Q2 2026 earnings estimates on adjusted EPS, EBIT, and revenue while reaffirming full-year guidance.
20:21
Jul 23
Jul 23
GE Healthcare reported preliminary Q2 revenue above expectations.
GE Healthcare reported preliminary Q2 revenue above expectations, sees adjusted EPS growth above forecasts, reaffirmed guidance, and announced CFO James Saccaro will step down.
20:19
Jul 23
Jul 23
GE Healthcare reports preliminary Q2 2026 revenue of 5.30 billion dollars beating estimates.
GE Healthcare reports preliminary Q2 2026 revenue of 5.30 billion dollars beating estimates and reaffirms guidance while announcing CFO James Saccaro's departure.
11:04
Jul 09
Jul 09
BMO initiates coverage on GE HealthCare with a Market Perform rating and a target price of $70.
21:56
May 21
May 21
Long medtech and digital health names as rising semiconductor content in medical devices drives.
Long medtech and digital health names as rising semiconductor content in medical devices drives growth in imaging, monitoring, robotics, and wearables.
HIGH
14:43
May 07
May 07
Long medical imaging hardware suppliers as improving MRI component demand signals a recovery.
Long medical imaging hardware suppliers as improving MRI component demand signals a recovery in production activity.
HIGH
10:07
May 02
May 02
GEHC laggard observation; no explicit trade call.
Watch GEHC: the author notes it is the only GE breakup piece that has not moved yet after GE Aerospace and GE Vernova outperformed, but gives no explicit ownership, buy/hold statement, or actionable bullish call.
MED
14:17
Apr 29
Apr 29
Bearish view on GEHC on the view that semiconductor memory cost inflation will hit margins.
Bearish view on GEHC on the view that semiconductor memory cost inflation will hit margins, as the CFO's estimates appear too low given supply chain pressures.
HIGH
12:30
Apr 29
Apr 29
Guidance was lowered due to significant raw material cost inflation (memory, oil, freight), which will pressure profit through the year, partly offset by price actions.
HIGH
12:25
Apr 29
Apr 29
The tweet suggests portfolio managers have built careers betting against Jay Saccaro's.
The tweet suggests portfolio managers have built careers betting against Jay Saccaro's leadership at GE HealthCare and Baxter, implying a bearish outlook on both stocks.
HIGH
03:30
Feb 24
Feb 24
GE HealthCare trades at 16x earnings, while its medtech peers trade at 29-37x. The company has a $21.8B order backlog and is pivoting to higher-margin AI diagnostics and recurring software revenue. The market misclassifies GEHC as a cyclical equipment maker, failing to recognize its transformation into a higher-growth, higher-margin medtech company. This misperception creates a significant valuation gap. The stock offers a compelling opportunity for multiple expansion as the market recognizes its successful pivot to AI and software, supported by a strong backlog and clear growth path. The pivot to AI and software may be slower or less profitable than anticipated; competition in the medtech space could intensify; hospital capital expenditure could slow down.
HIGH
00:29
Feb 24
Feb 24
Watch GEHC on rising diagnostic imaging demand.
Watch GEHC as continued growth in diagnostic isotopes and nuclear medicine activity supports utilization and demand for imaging equipment.
MED
13:30
Feb 04
Feb 04
Management tone is confident, reflected in initiating FY2026 guidance for EPS growth and margin expansion despite conservative China outlook, pointing to stronger 2027.
HIGH
08:30
Oct 21
Oct 21
Quest's Alzheimer's blood test (AD-Detect) revenue more than doubled in Q3 following new clinical guidelines, signaling rapid market adoption and potential pressure on amyloid PET and CSF testing. — Blood-based biomarkers are displacing more expensive imaging and CSF tests, which could reduce volumes for PET tracer suppliers and CSF assay platforms.
MED
About GEHC Analyst Coverage
Buzzberg tracks GEHC (GE HealthCare Technologies Inc. Common Stock) across 12 sources. 0 bullish vs 0 bearish calls from 14 analysts. Sentiment: evenly split. 21 total trade ideas tracked. Latest voices: DeItaone, SeekingAlpha, AlphaSense.